SUNPHARMANSESUN PHARMACEUTICAL IND L· PharmaceuticalsLowNeutral
Announced Tue, 14 Jul · 18:29 IST

Sun Pharmaceutical Industries Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.4%1-day move
₹1943.40
prior close
₹1955.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.3-0.4-0.3+0.4-0.6+0.8+0.8+0.0-0.0
Up moveDown movePending
AI summary

Sun Pharmaceutical Industries has informed exchanges that it will announce its first quarter results (quarter ended 30 June 2026) on 31 July 2026. The company has scheduled an hour-long earnings conference call at 6:30 PM IST on the same day, where senior management will discuss performance and take questions from analysts and investors. Participants can join via telephone (with universal numbers provided) or an audio webcast, and pre-registration is available to avoid wait time. A transcript of the call will be posted on the company's website afterwards. The press release was issued on 14 July 2026 by Company Secretary Anoop Deshpande.

Likely market impact

This is a routine pre-results announcement giving investors and analysts the date and time to tune into Sun Pharma's Q1 FY27 earnings call. No financial numbers are disclosed yet, so there is no immediate impact on the stock price, but traders should watch for the 31 July 2026 results for actual performance cues.